OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Therapeutic drug monitoring
Pharmacogenetic and Pharmacogenomics
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Economics
181 Publications
found
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis.
b
Journal of medical screening
March 1, 2022
p
Newborn Screening
c
Economics
Model
Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.
b
Future oncology (London, England)
February 1, 2022
p
Cancer
c
Economics
Review
Cost-Effectiveness of the COVID-19 Test, Trace and Isolate Program in Colombia.
b
Lancet regional health. Americas
February 1, 2022
p
COVID-19
c
Clinical outcomes
Economics
Model
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis.
b
Cost effectiveness and resource allocation : C/E
January 15, 2022
p
COVID-19
c
Clinical outcomes
Economics
Model
Point-of-care COVID-19 antigen testing in German emergency rooms – a cost-benefit analysis.
b
Pulmonology
January 1, 2022
p
COVID-19
c
Economics
Model
Operational efficiencies
Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil.
b
PloS one
January 1, 2022
p
COVID-19
c
Economics
Observational
Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
b
Inflammatory intestinal diseases
January 1, 2022
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Economics
Observational
Operational efficiencies
Patient-centeredness
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
b
PharmacoEconomics
December 1, 2021
p
Cancer
c
Economics
Model
Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States.
b
Pregnancy hypertension
December 1, 2021
p
Preeclampsia
c
Economics
Model
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis.
b
Journal of neurology, neurosurgery, and psychiatry
December 1, 2021
p
Newborn Screening
c
Economics
Model
Previous Page
1
2
3
4
5
6
…
19
Next Page
